trending Market Intelligence /marketintelligence/en/news-insights/trending/Jmuk3aE8_zGruqSy8o_LvQ2 content esgSubNav
In This List

ArQule raises $15.7M through private placement

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


ArQule raises $15.7M through private placement

ArQule Inc. raised $15.7 million after selling 13,938,651 shares of the company to certain investors, including BVF Partners LP.

The investors also received warrants to purchase up to an additional 3,123,674 shares of the company at $1.75 apiece.

ArQule intends to use the net proceeds to advance clinical trials of its proprietary pipeline, including derazantinib, ARQ 092, ARQ 531 and ARQ 751.